LAUSANNE, Switzerland--(BUSINESS WIRE)--Sep. 29, 2017--
Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) is
calling for funding proposals under PMI IMPACT, its USD 100 million
global initiative to support third party projects dedicated to fighting
illegal trade. Proposals can come from private, public, or
non-governmental organizations, and interested organizations must submit
their applications by November 15, 2017.
For this second funding round, PMI IMPACT will focus on initiatives that
address converging forms of illegal trade and related crimes, such as
corruption, money laundering, and organized criminal networks.
The projects can be implemented anywhere in the world, but should have
an impact in one or more of these geographic areas: Eastern Europe,
Middle East, North Africa, Tri-Border Area in South America, Central
America, South and Southeast Asia.
As highlighted by expert speakers from public institutions, law
enforcement, the private sector, and civil society at a two-day conference
on Combating Illicit Trade, held in London earlier this week with
the support of PMI IMPACT, illegal trade takes many forms – ranging from
the smuggling and counterfeiting of goods to human trafficking, and the
trade in drugs, arms, and wildlife. Illegal activities are frequently
interlinked and converge, as criminals exploit the same large-scale
trafficking routes and modes of operation.
The PMI IMPACT Expert Council will review and select the projects for
funding.
“We are looking forward to receiving cutting-edge proposals that will
help private and public organizations improve their knowledge and
efficiency in the fight against this growing concern worldwide" stated
Alain Juillet, member of the PMI IMPACT Expert Council.
Interested organizations can find information on how to apply for the
second funding round of PMI IMPACT here.
Philip Morris International Inc.
PMI is a leading international tobacco company, with six of the world's
top 15 international brands and products sold in more than 180 markets.
In addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of reduced-risk
products (“RRPs”). RRPs is the term PMI uses to refer to products that
present, are likely to present, or have the potential to present less
risk of harm to smokers who switch to these products versus continued
smoking. Through multidisciplinary capabilities in product development,
state-of-the-art facilities, and industry-leading scientific
substantiation, PMI aims to provide an RRP portfolio that meets a broad
spectrum of adult smoker preferences and rigorous regulatory
requirements. For more information, see www.pmi.com
and www.pmiscience.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170929005260/en/
Source: Philip Morris International
Media enquiries
Philip Morris International Media Office
T:
+41 (0)58 242 4500
E: media@pmi.com